Syremis Therapeutics
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$165M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Syremis Therapeutics is a biopharmaceutical company that develops novel medicines for mental health disorders such as schizophrenia, major depressive disorder, and bipolar depression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syremis Therapeutics Comparables
Compare Syremis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clexio Biosciences | 78% | |
| Draig Therapeutics | 78% | |
| Leal Therapeutics | 74% | |
Syremis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 |
Key People
Founding team and executive leadership
Syremis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series A |
| Pictet Group | Series A |
| GV | Series A |
| QVT Financial | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Grew 19% QoQ, from 32 to 38 employees.
- Dec 18, 2025
$165M Series A round completed.
Syremis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syremis Therapeutics's valuation, stock price, and market status.